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Aedes aegypti and Aedes albopictus mosquitoes are vectors of the RNA viruses chikungu-
nya (CHIKV) and dengue that currently have no specific therapeutic treatments. The
development of new methods to generate virus-refractory mosquitoes would be beneficial.
Cas13b is an enzyme that uses RNA guides to target and cleave RNA molecules and has been
reported to suppress RNA viruses in mammalian and plant cells. We investigated the
potential use of the Prevotella sp. P5-125 Cas13b system to provide viral refractoriness in
mosquito cells, using a virus-derived reporter and a CHIKV split replication system. Cas13b in
combination with suitable guide RNAs could induce strong suppression of virus-derived
reporter RNAs in insect cells. Surprisingly, the RNA guides alone (without Cas13b) also gave
substantial suppression. Our study provides support for the potential use of Cas13b in
mosquitoes, but also caution in interpreting CRISPR/Cas data as we show that guide RNAs
can have Cas-independent effects.
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A edes aegypti and Ae. albopictus are vectors of multiplehigh impact diseases caused by viruses with positive-strandRNA genomes such as dengue, chikungunya (CHIKV) and
Zika, which are major health burdens in many tropical and sub-
tropical regions and for which there are no effective licensed vac-
cines1–5. CHIKV causes severe arthralgia, which is a burden on
healthcare systems, and large-scale urban epidemics have been
recorded as recently as 20196–10. The development of new methods
to reduce the capacity of this mosquito to transmit arboviruses
would, therefore, be very valuable.
Prokaryotic clustered regularly interspaced short palindromic
repeats (CRISPRs) and CRISPR-associated (Cas) proteins con-
stitute a bacterial adaptive immune system against foreign nucleic
acids such as those of bacteriophages. Upon infection, foreign
nucleic acids are processed, and short fragments are integrated
into the CRISPR array which is subsequently transcribed to
produce guide RNAs. Different Cas proteins then use CRISPR-
RNA guides to recognise specific DNA or RNA targets and cleave
the complementary sequences11. Cas13 enzymes are RNA-guided
ribonucleases from the class 2 CRISPR-Cas system subtype VI-B
from Gram-negative bacteria12–14. The Cas13b enzymes from a
range of different bacteria have been shown to be able to process
their guides from longer RNAs and then use them to target and
cleave RNA12,13.
The Cas13b system has been proposed as an antiviral approach
to target viral RNA in plants15–17 and mammals18. Hence, we
wanted to explore if Cas13b could be a useful tool to target viral
RNA in mosquitoes.
Here we report the effect of the well-characterised Cas13b
from Prevotella sp. P5-12512 when used to target RNAs con-
taining sequences from CHIKV in Ae. aegypti and Ae. albopictus
mosquito cells. Two RNA guides were designed against the non-
structural protein 2 (nsP2) region of CHIKV and tested in
four different mosquito cell lines against (i) a chimeric firefly
luciferase reporter plasmid containing the CHIKV sequence
corresponding to nsP2 and (ii) a CHIKV split replication
system19,20 (Fig. 1). We demonstrate that Cas13b is capable of
identifying viral RNA sequences in mosquito cells and potentially
mediating the specific degradation of such sequences. Surpris-
ingly, the guide RNAs are also able to induce degradation in the
absence of Cas13b protein.
Results
Cas13b-independent effects with in vitro-transcribed guides.
We first aimed to determine if Cas13b was functional in different
mosquito cells lines using transfected guide RNAs. Two guide
RNAs were designed to target RNA sequences with different
predicted RNA structures within the CHIKV nsP2 coding region
(Supplementary Fig. 1, Supplementary Tables 1 and 2). The
guides were generated by in vitro transcription. A plasmid
expressing a reporter RNA containing the CHIKV target
sequence and firefly luciferase coding sequence (pCHIKVLuc,
Supplementary Fig. 2) was co-transfected into Ae. aegypti derived
Aag2, AF05 and AF319 cells, and Ae. albopictus derived C6/36
cells with the guide RNAs and a second plasmid expressing
Cas13b (pCas13b, Supplementary Figs. 2 and 3, Supplementary
Table 3). AF05 and AF319 are cloned derivatives of Aag2 cells,
with AF319 having a gene-edited knockout of Dicer-2 (Dcr2)21;
C6/36 is also deficient in Dcr222–24. Each guide RNA (guide 1 and
guide 2) was tested in two different quantities per transfection (10
and 40 ng, Supplementary Table 3).
In the presence of Cas13b, both guides (1 and 2) at both 10 and
40 ng reduced the expression of the CHIKV-luciferase reporter,
relative to a Renilla luciferase control, in all Ae. aegypti cell lines
(Fig. 2a–c, e–g, Supplementary Tables 4–6). In Ae. albopictus C6/
36 cells there was a similar effect, with the exception of guide 1 at
40 ng where no difference from the control was observed (Fig. 2d,
h, Supplementary Table 7). In all cell types the reduction in
expression was greater with guide 2 than guide 1 (Fig. 2,
Supplementary Tables 4–7). Unexpectedly, the guide-dependent
knockdown was independent of the presence of the plasmid
encoding Cas13b, as similar knockdown was observed when a
plasmid expressing ZsGreen (pZsG, Supplementary Fig. 2) was
used in place of the Cas13b plasmid (Fig. 2, Supplementary
Tables 4–7).
Partial Cas13b-dependent effects with U6-driven guides. We
speculated that the Cas13b-independent knockdown of gene
expression might be a consequence of the use of in vitro-
transcribed guide RNAs transfected into the cells. To test whether
the source of the RNA affected the requirement for Cas13b we
expressed the same guide RNAs under the control of an Ae.
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Fig. 1 Strategy for assessment of Cas13b mediated suppression in insect cell lines. In vitro-transcribed or U6-driven guides were used to assess if Cas13b
is able to target viral sequences in a a directly targeted chimeric reporter, or b a viral reporter responding to targeted viral replicase. CHIKV: chikungunya
virus sequence, Fluc: firefly luciferase, U6: Ae. aegypti U6-3 promoter, SG: CHIKV subgenomic promoter, Nluc: nanoluciferase.
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aegypti U6 RNA promoter (Supplementary Fig. 4, Supplementary
Table 3). In Aag2 cells, U6 promoter-driven guides were able
to direct Cas13b-dependent knockdown of target gene expression.
A similar amount of Cas13b-dependent knockdown was observed
from both guides (Fig. 3a, Supplementary Table 8). In other
mosquito cell lines knockdown of gene expression was only
partially Cas13b-dependent, with knockdown enhanced by the
presence of Cas13b (Fig. 3b–d, Supplementary Tables 9–11). In
these cell lines Cas13b-independent knockdown of reporter gene
expression was particularly noticeable with guide 2 and in AF319
and C6/36 cells (Fig. 3c–d, Supplementary Tables 10–11). Based
on the mean ratios of each group, a reporter expression of 36.7
(SD ± 10.9)% and 47.7 (SD ± 16.2)% was observed with guide 2 in
Cas13b-negative AF319 and C6/36 cells, respectively, in com-
parison to cells transfected with non-targeting control guide RNA
(AmC3, Supplementary Table 2).
Suppression of a CHIKV split replication system in vitro.
Having established that Cas13b could downregulate RNA with a
reporter system we were interested to test whether it was able to
affect replication of virus RNAs. Since direct work with CHIKV
in the UK requires high containment facilities, we used a split
replication system19,20 in which the replicase polyprotein
required for the replication of the viral RNA was supplied in
trans. A plasmid expressing a modified virus genome in which the
structural proteins were replaced by a nanoluciferase (Nluc)
reporter (pCHIKVRep1, Supplementary Fig. 2) was co-
transfected with plasmids expressing the viral replicase proteins
(pCHIKVRep2, Supplementary Fig. 2), either Cas13b (pCas13b)
or ZsGreen (pZsG), a firefly luciferase reference plasmid
(pHr5Fluc, Supplementary Fig. 2), and a plasmid expressing U6
promoter-driven guide RNAs (Supplementary Fig. 5, Supple-
mentary Table 3).
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Fig. 2 Cas13b-independent interference of a CHIKV-luciferase reporter
in insect cells. Aag2 (a, e), AF05 (b, f), Dcr2 knockout AF319 (c, g) and
C6/36 (d, h) cells were co-transfected with plasmid expressing Cas13b
(+ Cas13b) or ZsGreen (− Cas13b) and in vitro-transcribed guides at 10 ng
(a–d) or 40 ng (e–h) per well. Each bar represents the mean values of
firefly luciferase activity normalised to the Renilla luciferase activity (FF/RL),
the whiskers are the standard deviation from three independent
transfections with six replicates each and each dot represents a replicate.
Linear mixed model, except for h two-way ANOVA, as model could not be
fitted. ***P < 0.001, *P < 0.05 (Supplementary Tables 4–7). C: non-targeting
control guide (AmC3), 1: guide 1, 2: guide 2.
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Fig. 3 Partially Cas13b mediated interference of a CHIKV-luciferase
reporter in insect cells. Aag2 (a), AF05 (b), Dcr2 knockout AF319 (c) and
C6/36 (d) cells were co-transfected with plasmid expressing Cas13b
(+ Cas13b) or ZsGreen (− Cas13b) with U6 promoter-driven guide RNAs.
Each bar represents the mean values of firefly luciferase activity normalised
to the Renilla luciferase activity (FF/RL); the whiskers are the standard
deviation from three independent transfections with six to eight replicates
each and each dot represents a replicate. Linear mixed-effect model. ***P <
0.001, **P < 0.01 (Supplementary Tables 8–11). C: non-targeting control
guide (U6-AmC3), U6-1: guide 1, U6-2: guide 2.
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Consistent with the non-replicating reporter experiments with
U6 promoter-driven guides (Fig. 3), the presence of Cas13b and
either guide significantly reduced expression of Nluc from the
viral replication system in all cell types (Fig. 4, Supplementary
Tables 12–15). In the case of guide 1, knockdown was
accountable entirely by Cas13b-dependent viral RNA degrada-
tion. The Cas13b-transfected cells showed a significant drop in
Nluc expression (P < 0.001, Fig. 4, Supplementary Tables 12–15)
compared to the non-specific guide RNA control, but the controls
without Cas13b (ZsGreen) did not (P > 0.05, Fig. 4, Supplemen-
tary Tables 12–15).
Also consistent with previous experiments, guide 2 resulted in
a greater knockdown of viral replication system RNA levels.
Guide 2 gave a significant reduction of Nluc expression alone (P
< 0.001, Fig. 4, Supplementary Tables 12–15) and this effect was
enhanced by the addition of Cas13b (P < 0.001, Fig. 4, Supple-
mentary Tables 12–15) in all cell types.
Suppression of a CHIKV reporter with multi-guide arrays. A
limitation of using sequence-specific knockdown of viral RNA is
the potential for virus escape by small sequence changes in the
guide RNA target site. This is particularly problematic for systems
using relatively short targeting RNAs, such as shRNA, miRNA
and CRISPR/Cas-based systems. A potential solution to this
problem would be to express multiple guide RNAs inside the
same cell, thereby simultaneously targeting multiple sequences
within the target RNA. In its native prokaryotic context, Cas13b
processes longer RNAs to produce guides and has been shown to
be capable of doing this in mammalian cells12,13; we therefore
investigated whether our guide RNAs would function in the
context of an array of guides.
We designed U6 promoter-driven guide arrays with three
guide positions (Fig. 5a). One position in each array contained a
CHIKV targeting guide (guide 2) while the other two positions
had guides targeting sequences absent from the reporter (AmC1,
AmC3, Fig. 5a, Supplementary Table 2). Plasmids expressing each
of the arrays were co-transfected into mosquito cells with a
plasmid expressing either Cas13b (pCas13b) or ZsGreen (pZsG),
the CHIKV-luciferase reporter plasmid (pCHIKVLuc), and a
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Fig. 4 Effect of guide RNAs and Cas13b on the expression of a CHIKV
split replication system. a Aag2, b AF05, c Dcr2 knockout AF319 and d
C6/36 cells were co-transfected with plasmid expressing Cas13b
(+ Cas13b) or ZsGreen (− Cas13b) and U6 promoter-driven RNA guides,
together with a split replication system with nanoluciferase under the
control of a CHIKV subgenomic promoter, and a plasmid expressing firefly
luciferase as control for transfection efficiency. Each bar represents the
mean values of nanoluciferase activity normalised to the firefly luciferase
activity (NL/FL), the whiskers are the standard deviation from three
independent transfections with six replicates each and each dot represents
a replicate. a, b, d Linear mixed-effect model, c two-way ANOVA as model
could not be fitted. ***P < 0.001, **P < 0.01 (Supplementary Tables 12–15).
C: non-targeting control guide (U6-AmC3), U6-1: guide 1, U6-2: guide 2.
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Fig. 5 Use of a multi-guide array. a Pol III promoter (U6)-driven RNA guide
arrays used to test the effect of guide position on knockdown. Constructs
P1, P2 and P3 have the active guide (guide 2) in positions 1, 2 and 3,
respectively, of the three-position array, with guides against an absent
target (AmCyan) in the remaining positions. A mock array (PC) with all the
positions filled with non-targeting guides (AmC1, AmC2, AmC3) was used
as control. b–e Interference of the CHIKV-luciferase reporter with U6
promoter-driven RNA array in Aag2 (b), AF05 (c), Dcr2 knockout AF319
(d) and C6/36 (e) cells. Each bar represents the mean values of firefly
luciferase activity normalised to the Renilla luciferase activity (FF/RL); the
whiskers are the standard deviation from three independent transfections
with four to six replicates each and each dot represents a replicate. b–d
Linear mixed effects model, e two-way ANOVA. ***P < 0.001, **P < 0.01, *P
< 0.05, ns: not significant (Supplementary Tables 16–19). DR: non-variable
RNA guide backbone, U6T: U6 promoter terminator, P1: position 1, P2:
position 2, P3: position 3.
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reference plasmid expressing Renilla luciferase (Supplementary
Fig. 2, Supplementary Table 3).
Cas13b-dependent enhancement of suppression of the
CHIKV-luciferase reporter was detected in all cell types
(Fig. 5b–e, Supplementary Tables 16–19). Aag2 cells transfected
with Cas13b showed greater reduction of luciferase expression
compared to control cells transfected with the plasmid expressing
ZsGreen where guide 2 was in position 1 or position 2 in the
array, but no difference when it was in position 3 (Fig. 5b,
Supplementary Table 16). In all other cell lines (AF05, AF319,
C6/36) guide 2 was effective at mediating Cas13b-dependent
knockdown of the CHIKV-luciferase reporter in all three array
positions (Fig. 5c–e, Supplementary Tables 17–19). In Aag2,
AF05 and AF319 cells, the knockdown effect was higher in
position 1 compared to position 3 (Fig. 5b–d, Supplementary
Tables 16–18) but in C6/36 there was no significant difference in
the size of the reduction and the position of guide 2 in the array
(Fig. 5e, Supplementary Table 19).
Consistent with the U6-driven single guide experiments with
guide 2 (Fig. 3), we also observed Cas13b-independent knock-
down in Aag2, AF05 and AF319 cells (Fig. 5b–d, Supplementary
Tables 16–18). This effect was greater when the specific guide was
in position 1 compared to position 3 in Aag2 and AF05 cells
(Fig. 5b–c, Supplementary Tables 16–17), while the opposite
(lower in position 1 compared to position 3) was detected in
AF319 cells (Fig. 5d, Supplementary Table 18). No Cas13b-
independent interference was observed in C6/36 cells (Fig. 5e,
Supplementary Table 19).
Discussion
In this study we have shown that Cas13b RNA guides are able to
induce the knockdown of target genes in mosquito cells, both
through Cas13b-mediated enhancement of suppression and,
unexpectedly, through Cas13b-independent, sequence-specific,
RNA knockdown. This is in contrast to work describing the use of
Cas13b guides in mammalian and plant cells where RNA
knockdown was entirely dependent on the presence of
Cas13b12,17. We hypothesise that the phenomenon is dependent
on base-pair complementarity between the guide and the target
RNA, leading to recognition and processing of the target RNA by
cellular RNA interference (RNAi) systems. To further investigate
this, we used two Dcr2-defective cell lines, C6/36 and AF319.
Guide-only suppression was observed in these cell lines to a
similar degree to that observed in Aag2 and AF05 cells. We,
therefore, conclude that the guide-only suppression is not sub-
stantially dependent on Dcr2.
We used the chimeric CHIKV-luciferase reporter to assess if
Cas13b was functional in mosquito cells (Fig. 1). In these
experiments, expression of the CHIKV-luciferase reporter was
significantly reduced in the presence of Cas13b plus anti-CHIKV
guide RNA, or guide alone, relative to a Renilla luciferase control
(Fig. 3, Supplementary Fig. 4). This knockdown of the firefly
luciferase in the dual-luciferase assay indicates a reduction in the
amount of firefly luciferase mRNA present, as showed elsewhere
for RNAi25, consistent with direct targeting of the CHIKV-
luciferase mRNA by Cas13b or guide RNA.
The Cas13b-independent effect was detected due to the use of a
ZsGreen mock control plasmid (pZsG). Previous work in plant
and mammalian cells has not reported interference by the guides
alone12,17. In plants, the targeting guides were used without
Cas13b17, while in mammals, the authors used a catalytically
inactive dCas13b12. We speculate that the difference with our
results may be due to the cell type used, and that the dCas13b
may bind and sequester the guides such that these are less
available to endogenous RNAi pathways. The ability of dCas13
enzymes to bind to guides and recognise targets has been
demonstrated in the context of programmable RNA editing and
tracking of RNA in living cells26–28.
The degree of Cas13b-independent suppression varied between
different guides and delivery methods. For example, with trans-
fection of in vitro-transcribed guides suppression appeared
entirely Cas13b-independent (Fig. 2), whereas with U6 guides
addition of Cas13b generally enhanced suppression; in some
experiments, guide 1 alone did not show significant suppression
in the absence of Cas13b in comparison to guide 2 (Fig. 4).
The differences observed between the guides may be due to
several reasons. Based on predictions from RNAup29, which can
predict RNA accessibility based on RNA structural opening
energies, target site 2 is more accessible than target site 1 (Sup-
plementary Table 1). Cas13 activity is also dependent on the base
composition at the surrounding target site30; Cas13b from Pre-
votella sp. is reported to prefer open A-rich motifs for
cleavage18,31.
Cas13b-independent suppression is likely occurring in each
case, but not always to an extent detectable in our experiments
with the weaker guide 1. It is more surprising that addition of
Cas13b did not increase suppression with in vitro-transcribed
guides; possibly the Cas13b-independent effect was saturating,
though suppression with guide 1 was not particularly strong in
these experiments (Fig. 2). This emphasises the importance of
designing multiple guides, perhaps informed by bioinformatics
analyses such as RNA structure accessibility and testing the effi-
cacy of each guide in the presence and absence of Cas13b.
A possible explanation for the Cas13b-independent RNA
knockdown effect observed in our experiment is that double-
stranded RNA regions in the guide RNAs were recognised by the
cellular RNAi system. Since insects are heavily reliant on this
system as the primary adaptive response against viruses with
RNA genomes32,33, it is possible that insect cells would be more
sensitive to small highly structured RNA triggers than mamma-
lian cells. This is consistent with the observation that introducing
in vitro-transcribed guides into the cytoplasm was more potent at
stimulating Cas13b-independent knockdown than transcribing
the guides from an RNA polymerase III promoter in the nucleus
(Figs. 2 and 3), though the level of guides produced in those
experiments may not be equivalent.
The sequence-specific silencing observed in cells not expressing
Cas13b was not expected and the mechanism is not clear. It is
possible that Dcr2 recognises the stem–loop structures of the
guide RNA backbone and directs these to the Dcr2 small inter-
fering RNA pathway. However, as Dcr2 knockout AF319 cells
also showed some limited Cas13b-independent silencing, other
alternatives should be considered, such as a direct loading of
single-stranded RNA guides onto Ago1 and Ago2, the catalytic
components of RNA-induced silencing complexes (RISC)34–37. It
may be that the short, highly structured RNAs that are recognised
by Cas13b are loaded efficiently onto the RISC complexes even in
the absence of Dcr2 in insect cells. Indeed, recombinant mam-
malian Ago2 has been reported to bind to single-stranded RNAs
up to 73 nt long34. Another explanation could be possible
redundancies between Dcr2-mediated small interfering RNA,
Dcr1-mediated microRNA and the less known Piwi-interact-
ing RNA pathways, where interactions between these pathways
have been described21,38–41 and components of the latter two
pathways have been shown to be involved in antiviral responses
as well21,42–45.
Although U6-driven guides were previously used in human
and plant cells26, we were uncertain whether expressing Cas13b
guides from a U6 promoter would be effective in insect cells.
Normally, U6 RNAs are retained in the nucleus, whereas Cas13b
is translated in the cytoplasm and presumably acts there against
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viral RNAs. Despite this theoretical concern, our data with the
U6-driven guides demonstrate that Cas13b-independent and
Cas13b-dependent suppression could be achieved with U6-driven
guides (Figs. 3–5). These data also indicate that the γ-
monomethyl cap typical of pol III-transcribed U6 RNAs46 does
not prevent these activities.
Given standing genetic variation and mutation, a single guide
RNA is unlikely to provide adequate knockdown for all members
of a large population. This applies to mosquito genes but even
more so to RNA viruses, which have high mutation rates and the
potential for rapid evolution of escape mutants. Use of guide
RNAs for engineered refractoriness against such viruses is
therefore likely to require the use of multiple guides. One of the
attractive features of Cas13b is that it can process its guides from
a longer RNA13, which we demonstrated, using a chimeric
CHIKV-luciferase reporter (Fig. 5). We also assessed the effect of
positions in an array. We found strong suppression using a tar-
geting guide in either the first, second or third position in a three-
guide array. However, suppression was somewhat reduced as we
moved the guide more 3′. Since the most 5′ position will produce
a capped guide and the others will not, this is further evidence
that the cap is at least not detrimental to suppression. One pos-
sible explanation for the modest reduction in effectiveness in
more 3′ positions is that the sequence encoding the guide RNA
backbone includes four consecutive T nucleotides (Supplemen-
tary Table 1). Pol III transcription of U6 sequences terminates at
homopolymeric runs of T; T4 has been shown to provide partial
termination in mammalian cells47. It therefore seems plausible
that the reduced effectiveness from more 3′ positions simply
reflects reduced synthesis of the guide in these positions. It may
be that this sequence could be mutated to overcome this, similar
to work with Cas9 guide RNAs48, or a different Cas13 or guide
combination used. Another possibility is that Cas13b is thought
to process its guide array from 3′ to 5′13,49,50, which may affect
the relative utilisation of each guide.
A CHIKV split replication system19,20 was used to assess if
suppression of viral replication could be achieved (Fig. 1). In this
system, viral replicase leads to expression of a reporter from a
subgenomic promoter on a virus-derived RNA from which the
replicase coding sequences have been deleted. Reduction in viral
replicase, e.g. through targeting nsP2 mRNA coding sequence,
leads to reduction in reporter activity (Fig. 4, Supplementary
Fig. 5). A somewhat lesser degree of target interference was
observed with the split replication system (Fig. 4) in comparison
to the chimeric CHIKV-luciferase (Fig. 3), possibly due to fully
functional replication complexes produced before Cas13b inter-
ference, which would lead to basal amplification of the reporter.
The split replication system is a model for CHIKV; we consider
that it reproduces the relevant elements with respect to Cas13b
but it is possible that subtle differences mean that the effect, or the
magnitude of the effect on CHIKV itself might be rather different.
For example, the replicase RNAs are generated in the nucleus by
the Pol II polymerase, whereas viral RNAs are generated by virus-
encoded replicase in the cytoplasm; a nucleus-specific effect
might therefore show differential activity. On the other hand,
mutations identified with this split replication system have been
shown to have similar effects when introduced into replicating
virus19. Also, Cas13b-mediated RNA virus inhibition has been
demonstrated in both human and plant cells17,18.
We show here that Cas13b can be used to suppress a CHIKV
split replication system19,20. This and the viral inhibition
observed in other species17,18 suggests that Cas13b provides a
potential approach to engineering virus refractoriness in mos-
quitoes. Other Cas13 variants are also known, with broadly
comparable properties but potentially more efficient for specific
applications14,17. That guide RNAs have suppressing effects on
their own is interesting but unlikely to reduce their utility for
engineering refractoriness. Cas13 provides an alternative method
to targeting virus sequences rather than RNAi-based methods,
which have previously been shown to be potentially effective
against CHIKV, Zika and dengue viruses51–54. Sequence-based
approaches have advantages of specificity, but corresponding
difficulties in targeting multiple viruses, or even all sequence
variants of a given virus, and correspondingly may be prone to
resistance through the emergence of sequence variants. Similar
issues of resistance evolution likely apply to the use of mono-
clonal antibodies as the basis for virus resistance55. One way to
overcome such issues is by multiplexing—simultaneously target-
ing multiple sequences in the same or different viruses. Cas13b
has some advantages in the relative ease of multiplexing, parti-
cularly in its ability to process guide RNAs from a compact array
on a single primary transcript. We tested this potential by placing
an active guide at each of three positions in a three-element array
and found it to be effective in all positions (Fig. 5), though with a
modest reduction in effectiveness in more 3′ positions that may
relate to premature termination of transcription. Taken together,
these data are very encouraging for the future development of
antiviral effectors in mosquitoes based on RNA-directed Cas
systems.
Methods
Plasmid construction. AGG1186:pHr5Fluc (Genbank accession no. MT119956,
Supplementary Fig. 2), expressing firefly luciferase (Fluc) under the control of the
baculovirus Hr5-ie1 promoter, was made by modifying the pGL3 vector (Promega)
to insert a Hr5-ie1 promoter56, an intron from the Drosophila melanogaster alcohol
dehydrogenase (adh) gene57 and the Kozak consensus sequence58 upstream of the
coding region of Fluc. In all, 200 bp of the nsP2 sequence of CHIKV LR2006-OPY1
strain (ECSA genotype) were added to the 5′ end of Fluc with a ubiquitin fusion59
to build AGG1221:pCHIKVLuc (Genbank accession no. MT119958; Supplemen-
tary Fig. 2), which expresses the CHIKV-luciferase reporter.
To construct the Cas13b-expressing plasmid (AGG1328:pCas13b, Genbank
accession no. MT119959; Supplementary Fig. 2), the PspCas13b sequence of
Prevotella sp. P5-12512 was codon optimised for Ae. aegypti, synthesised in two
fragments (Twist Bioscience) and assembled with assembly PCR using Q5 high-
fidelity DNA polymerase (New England BioLabs). Cas13b was cloned into a vector
containing an ampicillin-resistance gene such that Cas13b was under the control of
the constitutive Hr5-ie1 promoter. A T2A ribosomal stutter was inserted on the 3′
end of Cas13b to attach ZsYellow marker protein for visualisation.
A plasmid expressing ZsGreen fluorophore under the control of the Hr5-ie1
promoter (AGG1201:pZsG, Genbank accession no. MT119955, Supplementary
Fig. 2) was synthesised as a mock control for pCas13b.
The AGG1080:pRL-Opie2 Renilla luciferase plasmid (Supplementary Fig. 2)
was provided by M. Anderson60 and was used as a reference plasmid to normalise
data for transfection efficiency.
Aedes aegypti U6-3 Pol III promoter was amplified from AeU6-702
(AGG1120)60 with primers 2704 and 2705 (Sigma-Aldrich; Supplementary
Table 20). The non-variable stem–loop backbone for the CRISPR-RNA of
PspCas13b (Cas13b)12 with BsaI restriction sites on each end to allow the
insertion of different RNA guide sequences was synthesised by assembly PCR
using primers 2706 and 2707 (Supplementary Table 20). These two PCR
products were inserted into the pJet1.2 vector (Thermo Scientific) by HiFi
assembly (New England BioLabs) to build plasmid AGG1399, the U6-guide
vector (Genbank accession no. MT119950; Supplementary Fig. 2). Oligos for
the variable RNA guide sequences (primers 2712 and 2713 for guide 1, and
primers 2714 and 2715 for guide 2; Supplementary Table 20) were annealed
and inserted into BsaI-linearised AGG1399 to build the different U6-single
guide plasmids (AGG1879:U6-1, Genbank accession no. MT119960, and
AGG1880:U6-2, Genbank accession no. MT119961). An AmCyan-targeting
guide (AmC3; Supplementary Table 2) was designed as the negative control
and cloned into the same vector (primers 2720 and 2721, AGG1881:U6-AmC3,
Genbank accession no. MT119962; Supplementary Table 20).
For the U6-driven guide array, two additional guides targeting AmCyan were
designed (AmC1 and AmC2; Supplementary Table 2). AmC1 and AmC3 were used
for positions that were not occupied by the CHIKV targeting guide 2 (Fig. 5a). A
mock array with guides AmC1, AmC2 and AmC3 (Fig. 5a) was built as a control
(AGG1875:U6-PC; Genbank accession no. MT119951). The arrays were assembled
with three variable RNA guide sequences, each followed by the non-variable
backbone, into the AGG1399 vector, such that the expression of the array was
controlled by the U6-3 promoter. Guide 2 was inserted into positions one, two or
three in AGG1876:U6-P1 (Genbank accession no. MT119954), AGG1877:U6-P2
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(Genbank accession no. MT119953) and AGG1878:U6-P3 (Genbank accession no.
MT119952), respectively, to test the activity of each position.
For the CHIKV split replication system, the plasmids Ubi-P1234-CHIKV
(pCHIKVRep2; Supplementary Fig. 2) and Ubi-Fluc-Gluc plasmids have been
previously described19,20. AGG1521:pCHIKVRep1 (Genbank accession no.
MT119957; Supplementary Fig. 2) was derived from Ubi-Fluc-Gluc by replacing
Fluc and Gluc with the fluorophore EGFP and Nluc, respectively.
In vitro-transcribed RNA guides and arrays. The nsP2 region of CHIKV was
targeted; this encodes the viral protease responsible for processing the viral poly-
protein into its functional components. Target structures and accessibility were
predicted with Mfold61 and RNAup30. Nucleotide constraints, protospacer flanking
site motifs, for target selection have not been reported for PspCas13b12. No
homologous targets in the RNA transcripts of Ae. aegypti (AaegL3 and AaegL5)
and Ae. albopictus (AaloF1) were found62,63 for each of the RNA guides designed.
DNA templates of single RNA guides for PspCas13b (guide 1, guide 2 and
AmC3 control) were synthesised by PCR using Phusion high-fidelity DNA
polymerase (New England BioLabs), a guide-specific 71–72 nt forward primer (10
nM; Sigma-Aldrich) containing a T7 promoter, variable guide sequence and the
first 18 nt of the non-variable stem–loop guide backbone as previously published12
(primers 2430, 2433 and 2946 for guide 1, guide 2 and AmC3 control, respectively;
Supplementary Table 20), and a 36 nt reverse complement primer (10 nM, Sigma-
Aldrich) coding for the guide backbone (primer 2323, Supplementary Table 20). In
vitro transcription and subsequent purification of guide RNAs was performed with
the MEGAscript T7 transcription kit (Invitrogen) and the MEGAclear
transcription clean-up kit (Invitrogen), respectively.
Cell culture. Aag2 cells (Ae. aegypti derived, RRID:CVCL_Z617) and C6/36 cells
(Ae. albopictus derived, RRID:CVCL_Z230) which have a truncated Dcr2 that is
not functional22,24,64 were used for transfections. Ae. aegypti Dcr2 CRISPR
knockout AF319 cells and its single-cell-derived parental cell line AF05 were
obtained from K. Maringer, University of Surrey, United Kingdom21,44,65. All cell
lines were authenticated by COI amplification and sequencing.
All cell lines were grown in Leibovitz-15 media (Gibco) supplemented with 10%
foetal bovine serum (Labtech), 100 IU/ml penicillin with 100 µg/ml streptomycin
(Gibco) and 10% tryptose phosphate broth (Gibco) at 28 °C without CO2 or
humidity control.
Cell transfections. Cells were seeded into 96-well microplates (Nunc) at a cell density
of 5 × 105 cells/well. When cells reached 70–80% confluence, they were transfected
using TransIT PRO reagent (Mirus Bio) according to the manufacturer’s instructions.
For each experiment, three independent transfections with 6–8 replicates were per-
formed. pRL-Opie2 or pHr5FLuc (Supplementary Fig. 2) was used as transfection
control where applicable. Amounts of plasmid and RNA mixtures used for transfec-
tions were optimised such that the total mass did not exceed 250 ng. A guide targeting
AmCyan, a gene not present in the reporter RNA, was used as a control to test the
specificity of the effect and a plasmid expressing the fluorescent reporter ZsGreen
(pZsG; Supplementary Fig. 2) was used in place of the plasmid-expressing Cas13b
(pCas13b, Supplementary Fig. 2) to determine if any knockdown observed was Cas13b
dependent without changing the total molar mass of DNA transfected. Specific details
for transfection mixtures are listed in Supplementary Table 3. Media were replaced
with unsupplemented media before transfection. Cells were incubated for 3–5 h post-
transfection at 28 °C before media were replaced with supplemented media. Cells were
harvested for dual-luciferase assay after 2 days.
Luciferase assays. Luciferase assays were performed as previously described60
with the Dual-Luciferase Reporter Assay (Promega) on a GloMax multi+ plate
reader (Promega). Briefly, cells were lysed with 30 µl 1× passive lysis buffer
(Promega) each after two washes with ion-free phosphate buffered saline (1× PBS)
and subjected to one freeze–thaw cycle at −80 °C. Luciferase assay reagent II
(Promega) and stop & glo reagent (Promega) were prepared according to the
manufacturer’s instructions and the luciferase activities were measured.
Statistics and reproducibility. In the experiments using pCHIKVLuc (Supple-
mentary Fig. 2, Supplementary Table 3), firefly luciferase activity was normalised
against Renilla luciferase activity to correct for transfection efficiency in each well (FF/
RL). In the experiments with the CHIKV split replication system (Supplementary
Fig. 2, Supplementary Table 3), the Nluc activity was normalised against firefly luci-
ferase activity (NL/FF). The FF/RL or NL/FF ratios were analysed with R (version
3.6.1), and wells that were not transfected were not included. For each experiment,
three independent infections with six replicates were performed. Linear mixed-effect
models fit by restricted maximum likelihood were preferentially used to investigate the
effect of Cas13b and its associated guides on the expression levels of the reporters used.
The lmer function in the lme4 package66 was used and the lmerTest package67
was used to calculate the t-tests using Sattherthwaite approximations to degrees of
freedom. Within each experiment, data were transformed as appropriate to fit a
normal distribution and models were run separately for each cell line and guide
concentration, where applicable. The presence of Cas13b and the guide used were set
as categorical fixed factors and the experiment as a random factor. Stepwise deletion of
non-significant (P > 0.05) variables was used to build the final model where all vari-
ables were significant (P < 0.05). Diagnostic plots of residuals were checked to ensure
that there was constant variance between residuals and model assumptions were met.
Two-way ANOVA was used where a model could not be fitted. Tukey’s honest
significant differences test (multcomp package68) was used for post hoc analyses.
Graphs were plotted and arranged with GraphPad Prism 8 and Illustrator CS6
(Adobe).
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
The data that support the findings of this study are available in Figshare at https://doi.
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